Allergan Note: Post Pfizer Merger Kibosh

The shares of Ireland-based pharmaceuticals manufacturer, Allergan, are down more than 15% since the US Department of Treasury basically put the kibosh on its proposed merger with Pfizer last week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.